Agraflora Organics International Inc (OTCMKTS:AGFAF) To unveil Its Winnipeg facility after Submitting Evidence Package To Health Canada


Agraflora Organics International Inc (OTCMKTS:AGFAF) is expected to open its 51,000-Square-foot situated in Winnipeg after its subsidiary The Edibles and Infusions Corporation submitted its Site Evidence Package to Health Canada. The new plant, which has been named Edibles Facility, is equipped with state of the art technology and will produce more than 250,000 pieces of precisely dosed edibles per eight-hour shift when fully operational.

The facility is equipped with highly efficient equipment and will provide both specific dosing and custom candies to satisfy customer specifications and regulatory requirements. The facility will also allow the company to reduce the degradation and contamination of cannabis inputs. Agraflora Organics already holds a Research and Development License from Health Canada and will use it to develop and refine the formalities and recipes for client edibles. This way, the company will reduce operational risks, improve customer satisfaction, and enable it to generate revenue after securing the Standard Processing License quickly.

In a statement, James Fletcher, a co-founder, and operational manager at EIC, said they are confident the timeline will allow the company to reach its first packaged sales in Q4 of this year. Added that they have designed an efficient and technologically advanced facility that will strategically position the company to handle large scale production. The facility will also allow the company to produce high-quality products at a low cost. The company will capitalize on its 100-year experience of confectionery manufacturing to produce high-quality cannabis-infused candies.

AgraFlora Enters into Agreement with ZenPharm Ltd

AgraFlora Organics, through its subsidiary Farmako GmbH, has entered into a binding supply term sheet with ZenPharm Ltd. The Term Sheet will the basis of signing a supply agreement to be completed in the coming weeks. Through the Term Sheet, AgraFlora will be in charge of supplying EU-GMP quality medical cannabis flowers, which are produced by Zenabis.  Through the agreement, AgraFlora will supply 1,500 kilograms of cannabis flower in Germany over a three-year term. AgraFlora will get the products in Germany before distributing them around the country under its brand.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.